RGS9 and bradyopsia: By elucidating how genetic mutations such as RGS9 (bradyopsia) and AIPL1 (LCA) affect vision, the CCT aids in precise diagnoses and the discovery of novel genetic causes of color vision disorders, potentially guiding the development of new therapies.